Login / Signup

Altered immunoexpression of DNA polymerase delta 1 catalytic subunit (POLD1) in colorectal cancer.

Przemysław StefaniakBartłomiej Emil KrazińskiJacek KieżunHanna MajewskaJanusz Godlewski
Published in: Contemporary oncology (Poznan, Poland) (2023)
Despite previous studies suggesting that POLD1 genetic alterations could be promising molecular biomarkers in CRC, our results do not support any prognostic significance of POLD1 expression in CRC.
Keyphrases
  • poor prognosis
  • single molecule
  • circulating tumor
  • genome wide
  • cell free
  • binding protein
  • case control
  • protein kinase
  • structural basis
  • circulating tumor cells